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Abstract
Fluoride (F) absorption from the rat stomach and urinary bladder, hamster cheek pouch, and the renal tubules of several
species are pH gradient-dependent. These observations led to the hypothesis that F crosses these epithelia in the form of the
undissociated acid, HF. Several recent reports, however, have provided evidence that F absorption from the rat small
intestine is insensitive to the lumenal pH. We report here our evidence that F uptake by rabbit intestinal brush border
membrane vesicles (BBMV) occurred rapidly and with an overshoot only in the presence of an inward-directed proton
gradient. In the absence of a proton gradient or in the presence of an outward-directed gradient, F uptake was slow and
without an overshoot. In the presence of an inward-directed proton gradient, F uptake was partially inhibited by DIDS
and DEP but not by diBAC. PCMBS inhibited F uptake by up to 83% in a dose-response manner. DiBAC appeared to
reduce intravesicular pH slightly but the other reagents had no effect. When the uptake buffer contained chloride or nitrate,
F uptake was partially inhibited compared to the mannitol or gluconate controls. It was concluded that F transport across
the rabbit intestinal BBMV occurs via a carrier-mediated process which may involve cotransport of F with H or exchange
of F with OH3. The inhibitory effects of DIDS, DEP and PCMBS may occur by affecting this carrier-mediated
transport. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Fluoride is absorbed from the oral cavity, stomach
and small intestine [1]. Whitford and Pashley [2]
found that the rate of £uoride absorption from the
rat stomach was directly related to the acidity of the
lumenal solution. The same relationship was noted in
studies with the rat urinary bladder [3], hamster
cheek pouch [4], and renal tubules of the rat [1,5],
rabbit [6], dog [7], and human [8^10]. These ¢ndings
formed the basis for the hypothesis that £uoride
crosses epithelia in the form of the undissociated
acid, HF (pKa = 3.4). Messer and Nopakun con-
¢rmed the pH dependence of £uoride absorption
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from the stomach but reported [11^13] that the ma-
jority of £uoride absorption occurred from the prox-
imal small intestine and was not pH-dependent.
Their ¢ndings prompted the present study which fur-
ther investigated the e¡ects of pH and pH gradients
on the intestinal transport of £uoride.
There are con£icting reports concerning the e¡ects
of the disulfonic stilbene, 4,4P-diisothiocyanostilbene-
2,2P-disulfonate (DIDS), on the transmembrane or
transepithelial transport of £uoride. DIDS is a po-
tent inhibitor of the cell membrane band 3 protein
anion exchanger. Whitford et al. [14] reported that
DIDS almost completely inhibited the e¥ux of chlo-
ride from red blood cells but had little or no e¡ect on
the e¥ux of £uoride. Similarly, Rouch et al. [6]
found no e¡ect of DIDS on the transport of £uoride
from the isolated, perfused cortical collecting duct of
the rabbit. Melvin et al. [15], however, used rat sub-
mandibular gland cell aggregates and found that £u-
oride uptake was partially inhibited by both bume-
tanide, an inhibitor of the Na/K/Cl cotransporter,
and DIDS. They concluded that £uoride movement
occurred primarily via chloride pathways and that
passive £uoride £uxes were of minor importance.
Along with the lack of a pH gradient e¡ect on the
intestinal absorption of £uoride, these divergent re-
sults stemming from studies with DIDS and red
blood cells, renal tubules and submandibular cells
suggest the possibility that £uoride transport may
share a common pathway with chloride that is pecu-
liar to certain cells, particularly glandular cells.
In the present study, we investigated the e¡ects of
pH, pH gradients, DIDS, diethylpyrocarbonate
(DEP), p-chloromercuribenzene sulfonate (PCMBS)
and bis(1,3-dibutylbarbituric acid)pentamethine oxo-
nol (diBAC) on £uoride uptake by rabbit small
intestinal brush border membrane vesicles (BBMV).
The results showed that £uoride uptake was depend-
ent on an inward-directed pH gradient and that
it was partially inhibited by DIDS, DEP and
PCMBS.
2. Materials and methods
2.1. Preparation of BBMV
The BBMV were prepared from the small intes-
tines of adult, female New Zealand white rabbits
by Mg2 precipitation in the presence of EGTA
[16]. After sacri¢ce of the animal with carbon diox-
ide, the proximal half of the small intestine was re-
moved and rinsed with ice-cold 0.9% saline. The mu-
cosa was gently scraped o¡ and homogenized in 20
vols. (v/w) of ice-cold 75 mM mannitol, 5 mM
EGTA, 20 mM Tris/NaOH bu¡er, pH 7.5, for 90 s
using a INST Blender. One mole/l MgCl2 was added
to the homogenate to adjust the MgCl2 concentra-
tion to 10 mM. After incubation for 30 min at 4‡C,
the mixture was centrifuged at 3000Ug for 15 min.
The supernatant fraction was then centrifuged at
60 000Ug for 30 min. The pelleted material contain-
ing the BBMV was suspended in preloading bu¡er,
consisting of 320 mM mannitol, 20 mM HEPES/Tris
pH 7.5. This suspension was again centrifuged at
60 000Ug for 30 min and the pellet was resuspended
in the same bu¡er using a syringe with a 25-gauge
needle. The protein concentration of the ¢nal brush
border membrane preparation was determined [17]
and adjusted to 10 mg/ml with preloading bu¡er.
The BBMV were then ready for transport studies.
2.2. Transport study
The £uoride uptake measurements were carried
out using a rapid ¢ltration technique [16]. In general,
uptake was initiated by addition of 40 Wl of the mem-
brane suspension containing 0.4 mg of membrane
protein to 160 Wl of uptake bu¡er containing a
known concentration of NaF. The mixture was shak-
en gently at room temperature in a gyratory shaker.
At the end of the incubation period, the uptake proc-
ess was stopped by adding 5 ml of ice-cold ‘stop’
bu¡er which was ¢ltered immediately through a
Millipore ¢lter (pore size, 0.65 Wm). The ¢lter was
washed four times with 5 ml of stop bu¡er to remove
the last traces of uptake bu¡er while retaining the
vesicles. Finally, the ¢lter was transferred to a petri
dish for £uoride analysis using the ion-speci¢c elec-
trode after di¡usion using the hexamethyldisiloxane
(HMDS)-facilitated method [1]. The amounts of £u-
oride analyzed typically ranged from 1 to 3 nmoles
which were within the linear portion of the standard
curve. The coe⁄cient variation for these amounts of
£uoride is 6 7%. Appropriate stop bu¡ers were used
based on the design of the di¡erent studies. The up-
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take rate for each time point or group was calculated
from the analysis of BBMV on six separate ¢lters.
The uptake bu¡ers, each of which contained
10 mM NaF (8 mM NaF after mixing with the
vesicle suspension), usually consisted of (1) 20 mM
MES/Tris, 150 mM NaCl, pH 5.0, (2) 20 mM
HEPES/Tris, 150 mM NaCl, pH 7.5, or (3) 20 mM
Tris/HEPES, 150 mM NaCl, pH 9.0. Mannitol, KCl
or other salts replaced NaCl in some experiments as
required.
2.3. Measurement of intravesicular pH
The dissipation rate of the pH gradient across
brush border membrane was estimated using a re-
cording spectro£uorimeter and BCECF acid, a pH-
sensitive £uorescent dye commonly used to estimate
transmembrane pH gradients. Since BCECF acid
does not cross biological membranes, the following
procedure was used to load BCECF acid into the
vesicles: the vesicles mixed with BCECF acid were
frozen in liquid nitrogen for 20 min, then thawed
with warm water. The freeze-thaw procedure was
repeated two more times. It was assumed that during
the freeze-thaw process, the vesicles would be broken
and resealed so that BCECF acid would be loaded
into the vesicles. We obtained good BCECF signals
using this method. Extravesicular BCECF was re-
moved by centrifugation at 60 000Ug for 30 min.
The pellets were resuspended in preloading bu¡er
and centrifuged again. The resulting membrane pel-
lets were washed twice with preloading bu¡er and
¢nally suspended in preloading bu¡er. The mem-
brane vesicles were then transferred to a cuvette to
obtain a baseline £uorescence signal. DIDS, DEP,
PCMBS or diBAC were then added to the cuvette
at ¢nal concentrations of 5 mM, 1 mM, 1 mM and
50 WM, respectively. Fluorescence signals were meas-
ured with a dual-wavelength spectro£uorimeter (Pho-
ton Technologies International, South Brunswick,
NJ) and using excitation wavelengths of 440 and
490 nm and an emission wavelength of 530 nm [18].
2.4. Materials
DIDS, DEP, PCMBS, MES, HEPES, Tris and
valinomycin were purchased from Sigma (St. Louis,
MO). BCECF and diBAC were obtained from Mo-
lecular Probes (Eugene, OR). All chemicals used
were of analytical grade.
Fig. 1. Time course of £uoride uptake by small intestinal
BBMV. BBMV were preloaded with 320 mM mannitol and 20
mM HEPES/Tris (pH 7.5). The uptake medium contained 150
mM NaCl, 10 mM NaF and 20 mM MES/Tris (pH 5.0), 20
mM HEPES/Tris (pH 7.5) or 20 mM Tris/HEPES (pH 9.0). Fi-
nal pH values of the uptake media after mixing with the
BBMV were 5.5, 7.5 and 8.5, respectively.
Table 1
In£uence of pH per se and a transmembrane pH gradient on £uoride uptake in small intestinal BBMV
pH F uptake (nmoles/mg of protein/15 s)
Intravesicular pH Extravesicular pH Gradient
9.0 9.0 0 31.36 þ 0.25
7.5 7.5 0 30.09 þ 0.62
5.5 5.5 0 0.26 þ 0.47
7.5 5.5 2.0 4.59 þ 0.73*
Membrane vesicles were preloaded with 320 mM mannitol and 20 mM HEPES/Tris (pH 7.5), 20 mM Tris/HEPES (pH 9.0) or
20 mM MES/Tris (pH 5.5). Uptake of £uoride (10 mM in uptake medium) was measured after a 15 s incubation. Extravesicular pH
values are the ¢nal pH values of the uptake media after mixing the membrane vesicles with the uptake bu¡er.
*P6 0.01 compared to other three groups.
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2.5. Preparation of solutions
DIDS was dissolved in the preloading bu¡er and
adjusted to 2 or 10 mM.
Fresh DEP stock solution (60 mM) was prepared
just prior to use by mixing 0.1 ml of commercially
available DEP solution (6.91 M) with 0.1 ml of etha-
nol and diluting the mixture with 11.3 ml of preload-
ing bu¡er.
PCMBS solutions were made by dissolving the in-
hibitor in preloading bu¡er.
DiBAC was dissolved in dimethyl sulfoxide
(DMSO) to 9.2 mM as stock solution.
2P,7P-bis(2-Carboxyethyl)-5-(and 6-)-carboxy£uo-
rescein (BCECF) acid stock solution was prepared
by dissolving 1 mg BCECF in 2 ml anhydrous
DMSO. This stock solution was divided into small
aliquots (200 Wl/tube) and stored at 320‡C.
Valinomycin was dissolved in ethanol.
2.6. Statistical analysis
Uptake measurements under each condition were
usually done by analyzing the £uoride on each of six
di¡erent ¢lters. The results are expressed as the
mean þ S.E. and analyzed for statistically signi¢cant
di¡erences using the unpaired Student’s t-test or
analysis of variance and Fisher’s PLSD post hoc
test. An K-value of 0.05 was selected a priori as the
indicator for signi¢cance.
3. Results
3.1. Time course of £uoride uptake
The time course of £uoride uptake by BBMV was
studied under three di¡erent experimental condi-
tions: (1) in the presence of an inward-directed H
gradient (pHi = 7.5, pHo = 5.0); (2) in the absence of
H gradient (pHi = pHo = 7.5); and (3) in the pres-
ence of an outward-directed H gradient (pHi = 7.5,
pHo = 9.0). The uptake of £uoride was rapid in the
presence of an inward-directed H gradient and it
exhibited the overshoot phenomenon, indicating
transient concentrative accumulation of £uoride in-
side the vesicles (Fig. 1). The uptake peaked at 15 s
and then decreased toward an apparent equilibrium
or steady state concentration at 60 min. The intra-
vesicular £uoride concentration at the overshoot was
2.3 times the equilibrium concentration observed at
Fig. 2. E¡ect of medium osmolarity on £uoride uptake. BBMV
were preloaded with 320 mM mannitol and 20 mM HEPES/
Tris (pH 7.5). Membrane vesicles were incubated for 60 min at
room temperature in uptake media containing 10 mM NaF, 20
mM MES/Tris (pH 5.5) and graded mannitol concentrations
(100^800 mM).
Table 2
The e¡ect of DIDS and DEP on £uoride uptake in small intestinal BBMV
Group F uptake (nmoles/mg of protein/15 s) % Reduction
Ethanol control 6.42 þ 0.47 0
DIDS (10 mM) 3.82 þ 0.30* 40
DIDS (2 mM) 5.27 þ 0.30* 18
DEP (5 mM) 3.89 þ 0.55* 39
DEP (1 mM) 3.74 þ 0.08* 42
DIDS (2 mM)+DEP (1 mM) 3.22 þ 0.29* 50
Membrane vesicles were preloaded with 320 mM mannitol and 20 mM HEPES/Tris (pH 7.5) and treated with DIDS for 60 min or
DEP for 10 min. Uptake of £uoride was measured after 15 s. The uptake bu¡er contained 20 mM MES/Tris (pH 5.0), 150 mM NaCl
and 10 mM NaF.
*P6 0.05 compared with the ethanol control group.
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1 h. In the absence of a H gradient or the presence
of an outward-directed H gradient, £uoride uptake
was slow, did not demonstrate an overshoot, and
reached an equilibrium or steady state concentration
at some time between 5 and 60 min.
3.2. In£uence of pH and transmembrane pH gradients
on £uoride uptake
In order to obtain speci¢c information on the role
of H concentrations per se, £uoride uptake was
compared in the presence and absence of a trans-
membrane proton gradient. The £uoride uptake rates
were determined after adjusting the pH of both the
intravesicular and extravesicular solutions to the
same values (pH = 9.0, 7.5 or 5.5). As shown in Table
1, the uptake rates under these conditions were close
to zero and not signi¢cantly di¡erent from each oth-
er. The rate of uptake in the presence of an inward-
directed H gradient (pHi = 7.5, pHo = 5.5) was
greater than the rates in the absence of an inward-
directed H gradient (P6 0.01). The results indicated
that pHi or pHo had little e¡ect on £uoride uptake
when there was no pH gradient.
3.3. E¡ect of medium osmolarity on £uoride uptake
The e¡ect of medium osmolarity on £uoride up-
take by intestinal BBMV was studied by measuring
the uptake of £uoride after 60 min incubations. The
extravesicular medium osmolarity was varied by
changing mannitol concentrations. A 60 min incuba-
tion period was chosen because the uptake of £uo-
ride into the vesicles reaches an apparent equilibrium
or steady state distribution after that amount of time
(Fig. 1). Increasing concentrations of mannitol, to
which the vesicles are impermeant, were correlated
with decreasing uptakes of £uoride (Fig. 2). Extra-
polation to in¢nite medium osmolarity (zero intra-
vesicular space) indicated no uptake. Thus, £uoride
uptake was completely due to transport into intra-
vesicular £uid space rather than binding to the mem-
brane.
3.4. E¡ects of DIDS and DEP on £uoride uptake
In these experiments, there was an inward-directed
H gradient (pHi = 7.5, pHo = 5.5). The vesicles were
pretreated with DIDS and DEP for 60 and 10 min,
respectively. The results (Table 2) showed that up-
take of £uoride into vesicles treated with 2 mM or
10 mM DIDS decreased 18 and 40% compared with
control group. Fluoride uptake into vesicles treated
with 1 mM or 5 mM DEP decreased 39 and 42%
compared with control group. The £uoride uptake
was decreased by 50% when the vesicles were treated
with a combination of 2 mM DIDS and 1 mM DEP.
Uptake by each of the treatment groups was signi¢-
cantly lower than that of the control group.
3.5. E¡ect of PCMBS on £uoride uptake
Small intestinal BBMV were treated with di¡erent
concentrations of PCMBS for 30 min and then
washed free of the reagent. Fluoride uptake was
measured in the presence of a H gradient
(pHi = 7.5, pHo = 5.5). The uptake was inhibited by
PCMBS in a dose-dependent manner (Fig. 3). The
rate of £uoride uptake was inhibited by 34% when
the PCMBS concentration was 0.1 mM and by 81%
when the PCMBS concentration was 5.0 mM. The
inhibition of uptake when the PCMBS concentration
was 10.0 mM was not signi¢cantly di¡erent from
that at 5.0 mM.
3.6. E¡ect of diBAC on £uoride uptake
The BBMV were treated on ice with 1, 10, and
50 WM diBAC for 10 min. The excess unreacted re-
Fig. 3. E¡ect of PCMBS on £uoride uptake in the presence of
pH gradient (pHi = 7.5, pHo = 5.5). Membrane vesicles prepared
from small intestine were treated with PCMBS for 30 min at
room temperature before adding the uptake bu¡er.
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agent was separated from the BBMV after centrifu-
gation at 60 000Ug for 30 min. Measurements of
£uoride uptake were carried out in the presence of
an inward-directed H gradient (pHi = 7.5,
pHo = 5.5). The results indicated that diBAC had
no e¡ect on F uptake (data not shown).
3.7. E¡ect of DIDS, DEP, PCMBS and diBAC on
transmembrane pH gradient
To test the possibility that the inhibitors may have
reduced £uoride uptake by reducing the transmem-
brane H gradient, the e¡ects of DIDS, DEP,
PCMBS and diBAC on transmembrane pH gradient
were done. The membrane vesicles were loaded with
BCECF and placed in cuvettes to determine the
baseline signals. DIDS, DEP, PCMBS and diBAC
were then added separately to the cuvettes to achieve
¢nal concentrations of 5 mM, 1 mM, 1 mM and
50 WM, respectively. The results are shown in Fig. 4.
Fig. 4A shows standard curve. BBMV were added
to bu¡ers at pH 7.5 (track 1), 6.0 (track 2) or 5.0
(track 3). Fig. 4B shows that £uoride in the uptake
bu¡er had no e¡ect on the £uorescence signal com-
pared to uptake bu¡er without £uoride. Fig. 4C and
D show the virtual lack of e¡ects of the inhibitory
Fig. 4. E¡ects of DIDS, DEP, PCMBS and diBAC on the transmembrane pH gradient. BBMV were preloaded with 320 mM manni-
tol and 20 mM HEPES/Tris (pH 7.5). The vesicles were then loaded with the pH-sensitive dye BCECF (96 WM) and placed in a cu-
vette. The membrane vesicles were then exposed to pH 5.0 uptake bu¡er (10 mM NaF, 20 mM MES/Tris, 150 mM NaCl). Fluores-
cence signals were measured with a dual-wavelength spectro£uorimeter using excitation wavelengths of 440 and 490 nm and an
emission wavelength of 530 nm. Panel A shows the standard curve. Tracks 1, 2 and 3 represent the pH 7.5, 6.0 and 5.0 standard, re-
spectively. In panel B, the drop of £uorescence signal of track 1 is the dilution e¡ect caused by adding 1.0 ml of preloading bu¡er
(pH 7.5) to 1.0 ml of the BBMV suspension (pH 7.5). Tracks 2 and 3 show the e¡ects of £uoride and non-£uoride uptake bu¡ers
(pH 5.0) on the £uorescence signal. Panel C shows the e¡ects of DIDS, DEP, PCMBS and diBAC (20 Wl of inhibitor solution was
added to the cuvettes at arrow) on the £uorescence signal. Two hours later (D), the same vesicles were exposed to pH 5.0 uptake
bu¡er containing 10 mM £uoride.
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agents on the £uorescence signal. The signal of the
diBAC group was slightly reduced when diBAC was
added to the cuvette (Fig. 4C, track 1) and continued
declining for 2 h (Fig. 4D, track 5). The signals of
DIDS, DEP and PCMBS cuvettes were unchanged
or only slightly decreased. The magnitude of £uores-
cence change induced by adding pH 5.0 uptake bu¡-
er after 2 h was similar in the control and DIDS-,
DEP-, PCMBS- and diBAC-treated membrane
vesicles (Fig. 4D). These results indicated that diBAC
slightly reduced intravesicular pH prior to adding pH
5.0 uptake bu¡er and that DIDS, DEP and PCMBS
had little or no e¡ect on intravesicular pH prior to
adding pH 5.0 uptake bu¡er, and did not facilitate
dissipation rate of imposed pH gradient.
3.8. F3-Cl3 and F33HCO33 exchange studies
To determine whether an anion exchange pathway
for £uoride was present in the BBMV, two anions
(Cl3 and HCO33 added as sodium salts) that might
exchange with £uoride were tested in the absence of
a pH gradient (pHi = pHo = 7.5). An outward Cl3 or
HCO33 gradient (50 mM) did not accelerate £uoride
in£ux (data not shown), indicating that there was no
F3-Cl3 or F33HCO33 exchange.
3.9. Fluoride conductance pathway study
To test for the presence of a membrane potential-
sensitive transport of £uoride ion in the BBMV, £u-
oride uptake was measured in response to a K dif-
fusion potential induced by valinomycin which in-
creases the K conductance of biological
membranes. The experiments were carried out in
the absence of a transmembrane pH gradient
(pHi = pHo = 7.5).
As shown in Fig. 5, £uoride uptake by the BBMV
Fig. 5. E¡ect of an inwardly redirected K di¡usion potential
on £uoride uptake. BBMV were preincubated as follows: A, 20
mM HEPES/TMA-OH (tetramethylammonium hydroxide), 100
mM potassium gluconate, 120 mM mannitol and valinomycin
(no K gradient); AP, 20 mM HEPES/TMA-OH, 320 mM
mannitol and valinomycin (K gradient); B, 20 mM HEPES/
TMA-OH, 100 mM potassium gluconate, 120 mM mannitol,
2 mM DIDS and valinomycin (DIDS without K gradient);
BP, 20 mM HEPES/TMA-OH, 320 mM mannitol, 2 mM DIDS
and valinomycin (DIDS with K gradient); C, 20 mM HEPES/
TMA-OH, 100 mM potassium gluconate, 120 mM mannitol
(no K gradient or valinomycin); CP, 20 mM HEPES/TMA-
OH and 320 mM mannitol (K gradient without valinomycin).
Valinomycin was added to the vesicle suspension (10 Wg/mg
protein). The composition of the uptake bu¡ers for all groups
was the same: 20 mM HEPES/TMA-OH, 10 mM NaF, 100
mM potassium gluconate and 100 mM mannitol. There was no
pH gradient in any of these experiments.
Fig. 6. E¡ect of Na and K gradients on F uptake in the absence (A, pHi = pHo = 7.5) and in the presence of a pH gradient (B,
pHi = 7.5, pHo = 5.5). BBMV were preloaded with 320 mM mannitol and 20 mM HEPES/Tris (pH 7.5). (A, no pH gradient) The up-
take medium consisted of 10 mM NaF, 20 mM HEPES/Tris (pH 7.5), and 300 mM mannitol or 150 mM NaCl or 150 mM KCl. (B,
pH gradient) The uptake medium consisted of 10 mM NaF, 20 mM MES/Tris (pH 5.5), and 300 mM mannitol or 150 mM NaCl or
150 mM KCl.
BBAMEM 77389 10-7-98
H. He et al. / Biochimica et Biophysica Acta 1372 (1998) 244^254250
in the presence of an inward-directed potassium gra-
dient (group AP) was higher than that in the absence
of a potassium gradient (group A, P6 0.05). Since
the uptake of group BP was higher than that of group
B (P6 0.05), the increased uptake (group BP) due to
an inward potassium gradient was not inhibited by
5 mM DIDS. Comparing group C to A, we found
that valinomycin itself had no e¡ect on £uoride up-
take (Ps 0.05). Comparing group CP to C, we found
that potassium gradient itself did not increase £uo-
ride uptake (Ps 0.05).
3.10. E¡ect of a sodium or potassium gradient on
£uoride uptake
The e¡ects of a Na or K gradient on F uptake
by the BBMV were examined in the presence and
absence of a pH gradient (Fig. 6). Under pH gra-
dient conditions (Fig. 6B, pHi = 7.5, pHo = 5.5), up-
take by the Na, K or mannitol groups was higher
than that of the corresponding groups in the absence
of a pH gradient shown in Fig. 6A (P6 0.01). Fluo-
ride uptake in BBMV in the Na and K groups
were not di¡erent with statistical signi¢cance
(Ps 0.05), but £uoride uptake in the mannitol group
was higher than that of Na and K groups
(P6 0.01). This may have been due to chloride in
the Na and K groups competing with £uoride
for the same transport system. In the absence of a
pH gradient (Fig. 6A, pHi = pHo = 7.5), uptake val-
ues were lower and were not di¡erent with statistical
signi¢cance (Ps 0.05). The results showed that £uo-
ride uptake was pH-dependent but not Na- or K-
dependent.
3.11. E¡ect of NO33 and Cl
3 on £uoride uptake
To further examine the possibility that chloride
competes with £uoride for the same transport sys-
tem, chloride and nitrate were tested for the ability
to interfere with the uptake of £uoride in the BBMV.
The experiments were done in the presence of an
inward-directed proton gradient (pHi = 7.5,
pHo = 5.5). The uptake bu¡ers contained mannitol,
potassium gluconate, di¡erent chloride concentra-
tions (10, 50 and 150 mM KCl) or 150 mM KNO3
and 10 mM sodium £uoride. Fig. 7 shows that the
uptake of £uoride was inhibited by 150 mM NO33
and by 50 and 150 mM Cl3 compared to mannitol
or gluconate control (P6 0.05). This suggested that
NO33 and Cl
3 can compete with £uoride for the
same transport system.
4. Discussion
Our data show that a proton gradient is required
for £uoride transport into the rabbit small intestinal
BBMV. In the presence of a proton gradient (out-
sides inside), £uoride rapidly crossed the mem-
branes and transiently accumulated within the
vesicles with an overshoot concentration that was
more than twice the equilibrium or steady state
concentration. The reduced uptake after 15 s ap-
peared to be due to the subsequent £uoride e¥ux
from the vesicles due to the progressive collapse of
the pH gradient. Whitford et al. [19] reported a sim-
ilar pH-dependent uptake and overshoot in their
study of £uoride uptake by Streptococcus mutans
6715.
On the other hand, £uoride uptake in the absence
of an H gradient or in the presence of an outward-
directed H gradient was very slow and did not dem-
onstrate an overshoot. Instead, £uoride uptake in-
creased slowly and reached what appeared to be an
Fig. 7. E¡ect of Cl3 and NO33 on F uptake in the presence of
a pH gradient (pHi = 7.5, pHo = 5.5). BBMV were preloaded
with 320 mM mannitol and 20 mM HEPES/Tris (pH 7.5). The
uptake media consisted of 10 mM NaF, 20 mM HEPES/Tris
(pH 7.5), and 300 mM mannitol, 150 mM potassium gluconate,
150 mM KNO3, or 10, 50 or 150 mM KCl. Potassium gluco-
nate was added where necessary to achieve the same osmolar-
ities among the uptake solutions.
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equilibrium value sometime between 5 and 60 min.
The equilibrium concentrations of £uoride were
nearly identical (Fig. 1), suggesting that the observed
di¡erences in the initial uptake rates were not due to
pH-induced alterations in the volume or integrity of
the vesicles.
We evaluated the role of H concentration on
BBMV £uoride uptake (Table 1). In the absence of
a proton gradient, the initial uptake rates of £uoride
in three di¡erent proton concentration groups (pH
5.5, 7.5 and 9.0) were not signi¢cantly di¡erent.
This indicated that it was the transmembrane proton
gradient, not the internal or external H concentra-
tion per se, that in£uenced £uoride transport.
DIDS has been found to covalently link to the
band 3 protein, an anion transport system [20].
DIDS can also inhibit Cl33HCO33 exchange
[21,22], SO34 3OH
3 [23], and Cl-oxalate exchange
[24,25]. Studies have shown that DIDS has no e¡ect
on £uoride e¥ux from red blood cells [14] nor £uo-
ride reabsorption from the cortical collecting duct of
the rabbit [6]. Uptake by rabbit submandibular cells,
however, was partially inhibited by DIDS [15]. In the
present study, 10 mM DIDS inhibited £uoride up-
take by intestinal BBMV by 40% (Table 2). This
suggests that £uoride transport in these glandular
systems involves a transport protein which is sensi-
tive to DIDS.
DEP, a histidine-speci¢c reactive reagent, has been
used to characterize proton-coupled transport sys-
tems. Histidyl residues have been shown to be
essential for the function of many transport systems
that are driven by H gradients. This includes the
transport systems responsible for the uptake of lac-
tose, lactate and proline into Escherichia coli mem-
brane vesicles [26], the uptake of Na into renal
BBMV [27] and E. coli membrane vesicles [28], the
uptake of peptide into renal BBMV [29] and the
uptake of cephradine via dipeptide carriers into small
intestinal BBMV [30]. The uptake of £uoride was
inhibited by DEP in the presence of a proton gra-
dient (Table 2). These results, like those from the
studies with DIDS, provide evidence that proton gra-
dient-dependent £uoride transport can use a trans-
port protein in which histidyl residues play an im-
portant role.
PCMBS inhibits the uptake of p-aminohippurate
[31], tetraethylammonium in renal brush border
membrane vesicles [32] and the uptake of tetraethy-
lammonium in rat renal basolateral membrane [33].
In addition to that, PCMBS also inhibits membrane
water channels [34,35]. In the present studies, £uo-
ride uptake was inhibited by PCMBS and the inhib-
ition was dose-dependent (Fig. 3). This indicated that
PCMBS is an important inhibitor of £uoride trans-
port and that sulfhydryl groups are involved in £uo-
ride transport system.
Grillo and Aronson [27], Sokol et al. [36] and
Kato et al. [30] indirectly demonstrated that DEP
did not facilitate dissipation of the H gradient.
Hori et al. [32] concluded that PCMBS had no e¡ect
on the dissipation rate of the H gradient in BBMV.
Kato et al. [30] found that the uptake of cephradine
into intestinal BBMV was inhibited by DEP but was
not inhibited by PCMBS in the presence of a proton
gradient. These results indicated that histidyl groups,
not sulfhydryl groups, are essential for the transport
of cephradine and indirectly demonstrated that
PCMBS did not facilitate dissipation of a H gra-
dient.
DiBAC slightly reduced intravesicular pH prior to
adding pH 5.0 uptake bu¡er (Fig. 4). DIDS, DEP
and PCMBS had little or no e¡ect on intravesicular
pH prior to adding pH 5.0 uptake bu¡er and did not
facilitate dissipation of the imposed pH gradient,
consistent with previous reports. Thus, it is likely
that the inhibitions of proton gradient-dependent £u-
oride transport by DIDS, DEP and PCMBS were
due to speci¢c interactions with one or several trans-
porters, rather than due to the decrease of the intra-
vesicular space or to the collapse of the proton gra-
dient.
DiBAC is the most potent known inhibitor of
band 3-mediated anion exchange in the red blood
cell [37]. Under our experimental conditions, £uoride
transport was inhibited by DIDS but not by diBAC.
These results suggest that DIDS and diBAC may
modify di¡erent parts of the band 3 protein or mod-
ify two di¡erent anion exchanger proteins. Other in-
terpretations of these discrepant results are species
di¡erences (rabbit vs. humans) or di¡erent properties
of the human erythrocytic anion exchanger and that
of the brush border membranes used in the present
studies. Further studies are needed to clarify this
subject.
We found (Fig. 5) that the £uoride uptake rate in
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the K di¡usion potential groups (AP, BP) were
slightly higher than occurred in the absence of a
K di¡usion potential (groups A, B, C, CP). The
increased uptake rate was not inhibited by DIDS.
This may indicate that an inwardly directed K dif-
fusion potential in small intestinal BBMV provides
the energy for £uoride uptake by establishing an in-
side-positive potential. This conductance pathway
appears to exist separately from the F3-H cotrans-
porter (or F3-OH3 exchanger), since the F3-H co-
transporter (or F3-OH3 exchanger) was proton gra-
dient-dependent and was partially inhibited by
DIDS, DEP and PCMBS.
The transport systems for many amino acids and
sugars are sodium-dependent [38]. The results of our
studies of the e¡ects of a sodium or potassium gra-
dient on £uoride uptake by the BBMV showed that
the process was Na- or K-independent. However,
our results demonstrated that high concentrations of
chloride and nitrate can compete with £uoride for
the same transport system(s) in small intestinal
BBMV (Fig. 7). These data suggest that £uoride,
chloride and nitrate can share the same transport
system. It is possible, however, that the rapid in£ux
of these ions may have interfered with £uoride up-
take via a conductance pathway.
Our ¢ndings suggest that £uoride absorption from
the intact rabbit intestine should be related to the
transmucosal pH gradient. In their studies of £uoride
absorption from the rat intestine, however, Messer
and Nopakun found no such relationship. The rea-
son for this discrepancy is not clear but may be re-
lated to species-speci¢c transport mechanisms.
Taken together, the experimental evidence from
our studies suggests that there are several pH gra-
dient-dependent, carrier-mediated mechanisms for
£uoride transport into rabbit small intestinal
BBMV. One apparent mechanism is not inhibited
by DIDS, DEP or PCMBS and may involve £uoride
uptake in the form of HF by di¡usion. Other mech-
anisms are inhibitable and sensitive to DIDS, DEP
and PCMBS. In these cases, £uoride appears to cross
the brush border membrane by a F3-H cotrans-
porter or F3-OH3 exchangers but only in the pres-
ence of an inward-directed proton gradient. Sulf-
hydryl and histidyl groups appear to play
important roles in this transport system.
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